Page 114 - 《中国药房》2022年6期
P. 114

[ 5 ]  BÖHM R,BULIN C,WAETZIG V,et al. Pharmacovigi-     disciplinary approach to manage an emerging challenge in
             lance-based drug repurposing:the search for inverse sig-  Hodgkin lymphoma therapy[J]. Cancers(Basel),2021,13
             nals via OpenVigil identifies putative drugs against viral  (23):6125.
             respiratory infections[J]. Br J Clin Pharmacol,2021,87  [11]  LEE K A,SHEPHERD S,BATTISTI N,et al. Ado-trastu-
             (11):4421-4431.                                     zumab emtansine-associated spider naevi in metastatic
        [ 6 ]  PENG L,XIAO K,OTTAVIANI S,et al. A real-world dis-  HER2-positive breast cancer[J]. J Case Rep,2019,8(4):
             proportionality analysis of FDA adverse event reporting  229-296.
             system(FAERS)events for baricitinib[J]. Expert Opin  [12]  TUDESQ J J,VINCENT L,LEBRUN J,et al. Cytomega-
             Drug Saf,2020,19(11):1505-1511.                     lovirus infection with retinitis after brentuximab vedotin
                                                                               +
        [ 7 ]  宋敏,张子雨,张宏伟,等.基于 FAERS 数据库的伊布替                     treatment for CD30 lymphoma[J]. Open Forum Infect Dis,
             尼不良事件信号挖掘研究[J].肿瘤药学,2021,11(4):                     2017,4(2):ofx091.
             406-412.                                       [13]  JOSHI A M,PROUSI G S,BIANCO C,et al. Microtubule
        [ 8 ]  黄佳,钟薇,王浩,等.基于美国 FAERS数据库的恩美曲                      inhibitors and cardiotoxicity[J]. Curr Oncol Rep,2021,23
             妥珠单抗不良事件信号挖掘与分析[J].中国医院药学杂                         (3):30.
             志,2022,42(1):49-53.                            [14]  CURIGLIANO G,LENIHAN D,FRADLEY M,et al.
        [ 9 ]  FORCE J,SAXENA R,SCHNEIDER B P,et al. Nodular     Management of cardiac disease in cancer patients through-
             regenerative hyperplasia after treatment with trastuzumab  out oncological treatment:ESMO consensus recommenda-
             emtansine[J]. J Clin Oncol,2016,34(3):e9-e12.       tions[J]. Ann Oncol,2020,31(2):171-190.
        [10]  VELASCO R,DOMINGO-DOMENECH E,SUREDA A.                      (收稿日期:2022-01-14  修回日期:2022-02-22)
             Brentuximab-induced peripheral neurotoxicity:a multi-                               (编辑:邹丽娟)


        

        (上接第739页)                                                pertension before and after operation[J]. Clin Pediatr(Phi-
        [18]  胡永狮,陈红,管云枫,等.神香苏合丸对狗冠状动脉两步                         la),2021,60(1):56-63.
             结扎法急性心肌梗塞的影响[J].中国现代应用药学,                      [25]  薛增明,李雅超,杨彦立,等.麝香保心丸联合尼可地尔对
             2000,17(2):99-101.                                  心绞痛后冠脉微循环障碍患者的疗效及一氧化氮、血管
        [19]  朱晓宇,刘洪翠,俞航萍,等.神香苏合丸防治心血管疾病                         紧张素Ⅱ、内皮素-1、C-反应蛋白的变化研究[J].辽宁中
             的实验研究[J].浙江理工大学学报(自然科学版),2016,                      医杂志,2020,47(6):112-114.
             35(4):630-635.                                 [26]  HAN W X,WEI Z J,DANG R L,et al. Angiotensin-Ⅱ
        [20]  钱承嗣,蒋峻.注射用丹参多酚酸联合曲美他嗪治疗老年                          and angiotensin-(1-7)imbalance affects comorbidity of
             冠心病心绞痛患者疗效及对炎性因子、血管内皮损伤和                            depression and coronary heart disease[J]. Peptides,2020,
             血脂的影响[J].中国老年学杂志,2021,41(21):4614-                  131:170353.
             4617.                                          [27]  ANGKANANARD T,ANOTHAISINTAWEE T,MCEVOY
        [21]  SAITO A,AMIYA E,SOMA K,et al. Fractional exhaled   M,et al. Neutrophil lymphocyte ratio and cardiovascular
             nitric oxide in adult congenital heart disease[J]. Nitric Oxide,  disease risk:a systematic review and meta-analysis[J].
             2020,100/101:45-49.                                 Biomed Res Int,2018,2018:2703518.
        [22]  STARK R J,KOCH S R,CHOI H,et al. Endothelial nitric  [28]  SHIVA G,GOTTO A M,MASSIMILIANO R,et al.
             oxide synthase modulates Toll-like receptor 4-mediated  Monocyte-to-HDL-cholesterol ratio as a prognostic marker
             IL-6 production and permeability via nitric oxide-indepen-  in cardiovascular diseases[J]. J Cell Physiol,2018,233
             dent signaling[J]. FASEB J,2018,32(2):945-956.     (12):9237-9246.
        [23]  CHAIKIJURAJAI T,TANG W H W. Reappraisal of in-  [29]  WU F Q,HE M A,WEN Q,et al. Associations between
             flammatory biomarkers in heart failure[J]. Curr Heart Fail  variants in IL-33/ST2 signaling pathway genes and coro-
             Rep,2020,17(1):9-19.                                nary heart disease risk[J]. Int J Mol Sci,2014,15(12):
        [24]  LIU Z,ZHANG M M,HUO Q,et al. Changes in ET-1,      23227-23239.
             plasma neuropeptide Y,and CGRP in child patients with        (收稿日期:2021-10-22  修回日期:2021-12-16)
             congenital heart disease complicated with pulmonary hy-                             (编辑:舒安琴)





        ·744 ·  China Pharmacy 2022 Vol. 33 No. 6                                    中国药房    2022年第33卷第6期
   109   110   111   112   113   114   115   116   117   118   119